Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04318886 · ClinicalTrials.gov registry record · Phase 3

Lay Coach-Led Early Palliative Care for Underserved Advanced Cancer Caregivers: The Project ENABLE Cornerstone RCT

A Phase 3 study of Family Members and Cancer Metastatic, sponsored by University of Alabama at Birmingham.

Active
Registry status
Phase 3
Development phase
387
Enrollment target
1
Study location

NCT04318886 is a Phase 3 study of Family Members and Cancer Metastatic that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 387 participants, below the 507-participant average among 11 other Family Members trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04318886, a Phase 3 study of Family Members and Cancer Metastatic, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
387 participants
Enrollment target
1
Study location

Study Summary

Many of the 2.8 million family caregivers (FCGs) of persons with advanced cancer are underserved, particularly African-Americans and rural-dwellers in the Southern U.S.. Most have poor access and awareness of community-based palliative care services and have received no formal support or training despite providing assistance to their relatives an average of 8 hrs/day. Providing intense care and witnessing a close friend or family member struggle with advanced cancer can result in FCGs experiencing marked distress, particularly as their care recipients near end of life (EOL). Reports from NCI and NINR caregiving summits, systematic reviews, and the National Academy of Medicine have highlighted major limitations of cancer caregiver interventions, including a lack of attention to underserved populations and cost, poor scalability, over reliance on highly-trained professionals (e.g., nurses, psychologists, behavioral therapists), lengthy sessions over a short duration, and a lack of demonstrated impact on patient outcomes and healthcare utilization. To address this gap, the investigators have developed and tested feasibility and acceptability of a lay navigator-led early palliative care intervention called ENABLE Cornerstone for rural and minority family caregivers of persons with advanced cancer in the Southern U.S.. Evolving out of the team's prior trials and community stakeholder formative evaluation work, this multicomponent intervention is based on Pearlin's Stress-Health Process Model where lay navigators, overseen by an interdisciplinary outpatient palliative care team, employ health coaching techniques and caregiver distress screening to behaviorally activate and reinforce psychoeducation on managing stress and coping, getting and asking for help, improving caregiving skills, and decision-making/advance care planning over 6 brief in-person/telephonic sessions plus monthly follow-up from diagnosis through early bereavement. This proposed hybrid type I randomized

Interventions

  • BEHAVIORAL ENABLE Cornerstone

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 387 participants
Start Date 2021-01-07
Est. Completion 2027-06-30
Phase Phase 3

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04318886

The ClinicalTrials.gov registry entry for NCT04318886 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 387 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 507-participant average among 11 other Family Members trials with a reported enrollment target (24% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Family Members appearing as the primary indexed condition, and to 1 intervention - of which ENABLE Cornerstone is the first listed.

NCT04318886 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT04318886 about?

NCT04318886 is a clinical study titled "Lay Coach-Led Early Palliative Care for Underserved Advanced Cancer Caregivers: The Project ENABLE Cornerstone RCT". Many of the 2.8 million family caregivers (FCGs) of persons with advanced cancer are underserved, particularly African-Americans and rural-dwellers in the Southern U.S.. Most have poor access and awareness of community-based palliative care services and have received no formal support or training de...

What is the current status of trial NCT04318886?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 387 participants. The study started on 2021-01-07. Estimated completion is 2027-06-30.

What conditions does trial NCT04318886 study?

This clinical trial studies the following conditions: Family Members, Cancer Metastatic.

What interventions are being tested in trial NCT04318886?

The interventions under investigation include: ENABLE Cornerstone (BEHAVIORAL).

Who is sponsoring clinical trial NCT04318886?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04318886 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Family Members

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.